Addex Therapeutics Ltd
ADXN | NASDAQ
$3.53
+$0.13 (+3.98%)
At close: Sep 21, 2026, 4:00 PM ET
$3.32
-$0.21 (-5.95%)
Pre-market:
Sep 22, 2026, 4:31 AM ET
TTM Period Ending | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -6.95M | -6.71M | -6.1M | -6.05M | 8.67M | 7.06M | 5.4M | 4.32M | -11.24M | -10.56M | -11.35M | -12.84M | -17.39M | -20.8M | -21.58M | -21.07M | -18.54M | -15.35M | -13.05M | -12.77M | -11.19M |
Depreciation & Amortization | 16.16K | 8.46K | 30.16K | 81.61K | 191.88K | 192.7K | 248.28K | 270.09K | 233.11K | 305.95K | 302.22K | 304.15K | 312.09K | 323.14K | 330.46K | 340.88K | 345.8K | 347.61K | 351.72K | 362.99K | 371.24K |
Stock-Based Compensation | 22.91K | 24.92K | 24.92K | 63.37K | 110.59K | 471.7K | 860.91K | 1.31M | 1.75M | 1.79M | 2.09M | 2.5M | 2.67M | 3.68M | 3.27M | 2.75M | 2.43M | 1.18M | 1.13M | 1.06M | 1.06M |
Other Working Capital | 326.99K | 377.11K | 213.33K | 136.81K | -2.02M | -2.17M | -596.26K | -898.45K | 238.6K | -92.76K | -1.85M | -1.1M | 199.06K | 340.01K | 1.48M | 1.54M | -444.54K | 436.27K | 1.71M | 1.15M | -1.14M |
Other Non-Cash Items | 4.23M | 4.12M | 3.79M | 3.75M | -10.84M | -11.91M | -12.06M | -12.96M | 615.29K | 653.26K | 285.79K | 213.38K | 136.95K | 204.13K | 200.72K | 355.99K | 586.96K | -144.97K | -15.52K | 245.93K | 166.29K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -389.21K | -394.47K | -403.62K | -403.62K | -14.42K | -9.15K | n/a | n/a | -11.54K | 27.31K | 27.31K | 27.31K | 53.16K | 33.82K | 52.71K |
Change in Working Capital | 350.92K | 393.09K | 678.59K | 714.8K | -1.91M | -1.18M | -36.45K | -367.18K | 1.22M | 213.76K | -1.75M | -1.05M | 313.4K | 157.68K | 1.48M | 1.43M | -1.64M | -761.57K | 473.86K | -7.95K | -1.25M |
Operating Cash Flow | -2.33M | -2.16M | -1.58M | -1.44M | -3.78M | -5.37M | -5.97M | -7.83M | -7.83M | -7.99M | -10.44M | -10.88M | -13.95M | -16.44M | -16.31M | -16.16M | -16.78M | -14.71M | -11.06M | -11.07M | -10.79M |
Capital Expenditures | n/a | n/a | n/a | -1.27K | -1.27K | -1.27K | -2.48K | -1.88K | -4.37K | -6.84K | -5.64K | -5.54K | -3.05K | -581 | -25.07K | -26.16K | -28.39K | -31.55K | -55.15K | -54.17K | -54.06K |
Cash Acquisitions | 56.67K | 56.67K | 44.17K | -20.47K | -20.47K | -20.47K | -4.57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -2.44K | -2.44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8 | 3.55K | 3.55K | 3.55K | 3.65K | 1.24K | 1.24K | 1.24K | 1.15K | n/a | n/a |
Other Investing Acitivies | -3.2K | -3.2K | n/a | n/a | 4.67M | 4.67M | 4.67M | 4.67M | n/a | n/a | n/a | 3.56K | 3.56K | 3.56K | 3.65K | 1.24K | 1.24K | 1.24K | 1.15K | n/a | n/a |
Investing Cash Flow | 51.03K | 51.03K | 44.17K | -21.75K | 4.65M | 4.65M | 4.66M | 4.67M | -4.37K | -6.84K | -5.65K | -1.99K | 503 | 2.97K | -21.42K | -24.92K | -27.15K | -30.31K | -54K | -54.17K | -54.06K |
Debt Repayment | -7.07K | -7.31K | -7.22K | -7.56K | -8.75K | -73.69K | -140.97K | -210.92K | -234.51K | -281.79K | -279.71K | -277.71K | -327.03K | -288.08K | -295.01K | -303.56K | -307.08K | -309.62K | -321.81K | -338.68K | -353.41K |
Common Stock Repurchased | -31.82K | -28.64K | -28.64K | -25.9K | n/a | -4.55K | -4.55K | -22.88K | -38.11K | -33.57K | -33.57K | -15.23K | -5.03K | -13.59K | -13.59K | -13.59K | -8.56K | n/a | n/a | 12.12K | -25.03K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.56K | -1.76K | -206.18K | -203.9K | -20.88K | 215.5K | -760.17K | -878.68K | 3.47M | 3.2M | 4.27M | 7.42M | 2.79M | 2.17M | 6.76M | 3.71M | 3.41M | 2.75M | -1.91M | -1.91M | -1.51M |
Financial Cash Flow | 1.16M | 1.19M | 1.11M | 744.97K | 38.36K | 104.92K | 48.29K | -140.18K | 4.4M | 5.26M | 5.15M | 9.53M | 4.88M | 3.1M | 11.43M | 7.15M | 6.87M | 16.4M | 8.74M | 8.73M | 9.05M |
Net Cash Flow | -1.88M | -1.69M | -1.16M | -1.49M | 1.2M | -523.74K | -1.4M | -3.38M | -3.97M | -3.09M | -5.67M | -1.64M | -9.29M | -13.53M | -5.06M | -9.3M | -10.33M | 1.79M | -2.33M | -2.56M | -1.91M |
Free Cash Flow | -2.33M | -2.16M | -1.58M | -1.44M | -3.78M | -5.37M | -5.97M | -7.83M | -7.83M | -8M | -10.45M | -10.89M | -13.96M | -16.44M | -16.34M | -16.18M | -16.81M | -14.74M | -11.11M | -11.13M | -10.84M |
Adj. Free Cash Flow | -2.35M | -2.19M | -1.6M | -1.51M | -3.89M | -5.85M | -6.84M | -9.13M | -9.58M | -9.79M | -12.54M | -13.39M | -16.63M | -20.12M | -19.61M | -18.94M | -19.24M | -15.92M | -12.24M | -12.19M | -11.91M |
Maintenance CapEx | n/a | n/a | n/a | -1.27K | -1.27K | -1.27K | -2.48K | -1.88K | -1.88K | -1.88K | -678 | -580 | -580 | -580 | -25.07K | -24.49K | -24.49K | -27.65K | -3.16K | -3.85K | -3.85K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.49K | -4.96K | -4.96K | -4.96K | -2.47K | -1 | n/a | -1.67K | -3.9K | -3.9K | -51.99K | -50.32K | -50.21K |
Owner Earnings | -2.33M | -2.16M | -1.58M | -1.44M | -3.78M | -5.37M | -5.97M | -7.83M | -7.83M | -7.99M | -10.44M | -10.88M | -13.95M | -16.44M | -16.34M | -16.18M | -16.81M | -14.73M | -11.06M | -11.08M | -10.79M |
Add to Watchlist
Select watchlists to add or remove ADXN